PROM1 and neoplasm: Interestingly, CD45−/CD44+ tumor cells (a mesenchymal marker) were decreased (Fig. 2H), but not CD45-/CD133+ tumor cells (hematopoietic marker) (Supplementary Figure 4B) in the p65 KO tumors compared to control tumors.